Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
ASBPCompany Name
ASPIRE BIOPHARMA HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQASPIRE BIOPHARMA HOLDINGS INC - Price to Operating Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ASBP - P/OCF Historical data
| Date | Market Capitalization | Net Cash Flow - Operations | Price to Operating Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ 19.76M | $ -304.72K | 0 |
| 3/31/2025 | $ 11.79M | $ 243.28K | 48.45 |
| 12/31/2024 | $ 24.94M | $ -265.19K | 0 |
| 9/30/2024 | $ 90.02M | $ -2.98M | 0 |
| 6/30/2024 | $ 87.2M | $ -3.13M | 0 |
| 3/31/2024 | $ 88.29M | $ -2.73M | 0 |
| 12/31/2023 | $ 99.35M | $ -653.11K | 0 |
| 9/30/2023 | $ 98.09M | $ -532.85K | 0 |
| 6/30/2023 | $ 94.86M | $ -454.55K | 0 |
| 3/31/2023 | $ 378.42M | $ -302.97K | 0 |
Key Performance Insights, Last 5 Years
- ASPIRE BIOPHARMA HOLDINGS INC's latest trailing twelve months (TTM) P/OCF stands at 0.
- Over the past 5 years, ASPIRE BIOPHARMA HOLDINGS INC's average P/OCF has been 48.45.
- The median P/OCF for ASPIRE BIOPHARMA HOLDINGS INC during this period was 48.45
- ASPIRE BIOPHARMA HOLDINGS INC reached its highest P/OCF over the past 5 years at 48.45.
- The lowest P/OCF recorded by ASPIRE BIOPHARMA HOLDINGS INC in the same timeframe 48.45
Similar metrics to P/OCF:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Free Cash Flow to Operating Cash Flow - [Calculation] The Free Cash Flow to Cash Flow from Operations ratio, describes how much of a company’s operating cash flow [NCFO] is free to be invested after capital expenditures [CapEx].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Price to Operating Cash Flow
[Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].Market Cap / CF - Operations
(=) P/OCF P/OCF for ASPIRE BIOPHARMA HOLDINGS INC is calculated as follows: Market Cap [ $ 0 ] / CF - Operations [ $ -238.6K ]
(=) P/OCF [ 0 ] ASBP - Price to Operating Cash Flow, Last 5 years
48.45
Minimum
Mar 31, 2025
48.45
Maximum
Mar 31, 2025
48.45
Average
48.45
Median
P/OCF Benchmark AnalysisMarket
The chart above depicts the distribution of P/OCF for companies in the Total Stock Market. The average P/OCF of the companies is 13.1 with a standard deviation of 8.82.
The following table provides additional summary stats:
P/OCF in the Market:
| filtered constituents | 2.56K |
|---|---|
| min | 0.08 |
| max | 42.19 |
| average | 13.1 |
| median | 10.76 |
| std | 8.82 |